Dutch Beverage Stock News

Magnum Ice Cream shares have gained 21.8% year to date, yet the broader valuation checks and market multiples suggest the stock may now be pricing in a lot of good news rather than offering clear value. The 21.8% year to date return points to strong optimism already reflected in Magnum Ice Cream's share price. Heatwave driven sales strength and recent product momentum can support investor expectations, while an ongoing antitrust review may limit how much confidence the market is willing to...

Global markets are wrestling with sticky inflation, shifting central bank expectations and sharp moves in energy prices. That mix is creating plenty of noise in share prices, but it is also surfacing companies where cash flow potential appears out of sync with current valuations. The Undervalued Stocks Based On Cash Flows screener focuses on stocks that the SWS DCF model views as trading below fair value, with cash generation front and centre. For investors who care about what a business can...

ASML Holding has surged over the past year, yet its recent pullback and a low overall value score leave investors weighing a strong share price run against checks that do not point to a clear bargain. ASML Holding has delivered a 142.6% return over the last year, which puts recent share price weakness into the context of a strong prior run. Rising demand for AI related chipmaking equipment can support high expectations for ASML Holding. At the same time, emerging Chinese DUV lithography...

Koninklijke BAM Groep (ENXTAM:BAMNB) is in focus after reporting half year 2026 results that highlight higher adjusted EBITDA, improved operating margins and a strong €12.6b order book, despite higher taxes and project costs in Ireland. See our latest analysis for Koninklijke BAM Groep. At a share price of €11.59, Koninklijke BAM Groep has a 1-day share price return of 1.22% and a 7-day share price return of 5.36%, while its 30-day share price return is down 4.84%. However, the 90-day share...

Investors were underwhelmed by the solid earnings posted by Koninklijke Heijmans N.V. ( AMS:HEIJM ) recently. We did...

One of the biggest stories of last week was how Pharming Group N.V. ( AMS:PHARM ) shares plunged 20% in the week since...

The market has been willing to pay up for Brunel International, with the stock closing at €7.51 and trading on a very high P/E of 124x, even as trailing net profit margins sit at only 0.3%. That tension between rich valuation and thin profitability set the stage for today. The headline from these results is simple. Brunel kept gross margin broadly steady at 17.3% and delivered about €14m of underlying EBIT in the first half, yet the core story is still a profit squeeze that leaves little room...

Corbion heads into this earnings season with its stock parked around €18.93 after a flat few months, even as trailing earnings grew much faster than revenue and the P/E multiple sits well below both peers and the wider industry. The market has treated that gap as a value trap. The fresh H1 2026 numbers turn the spotlight onto one question: Is this a quality earnings rebound with improving net margins, or just a temporary lift sitting on top of a highly leveraged balance sheet that still makes...

Why Flow Traders’ Latest Earnings Matter For Investors Flow Traders (ENXTAM:FLOW) has drawn renewed attention after reporting half year 2026 earnings, with net income of €91.18 million and basic earnings per share from continuing operations of €2.07. See our latest analysis for Flow Traders. Flow Traders’ latest half year earnings and strong returns on trading capital appear to have supported momentum, with a 1-day share price return of 2.72% and a year-to-date share price return of 4.66%...

Fugro heads into this earnings season with its stock under pressure. The share price closed at €8.51 on 31 July and has fallen about 31% over the past three months as investors react to a tougher offshore wind market and a string of weak returns. The headline from H1 2026 is not about revenue. It is about strain on profitability and the balance sheet. Fugro remains loss making, reporting a net loss of €62m. Impairments on vessels and the removal of full year margin improvement guidance keep...

ING Groep (ENXTAM:INGA) is back in focus after reporting strong Q2 2026 results, upgrading its guidance for 2026 and 2027, and highlighting higher return on tangible equity and capital ratios. See our latest analysis for ING Groep. That strong Q2 update has come alongside clear share price momentum, with ING Groep’s 90 day share price return of 22.97% feeding into a 24.32% year to date gain and a 64.27% 1 year total shareholder return. Together, these figures suggest investors are reassessing...

Wolters Kluwer (ENXTAM:WKL) is in focus after its Health segment announced a collaboration with Epic to embed clinical decision support, medication intelligence, and patient education tools directly into Epic workflows for resource constrained providers. See our latest analysis for Wolters Kluwer. The collaboration news lands after a volatile spell for Wolters Kluwer, with the share price at €67.88 and a 30 day share price return of 18.67% following a year to date share price decline of...

DSM-Firmenich stock has quietly rerated into earnings, with the share price up about 47% over the past three months and closing at €93.38 on 31 July. Expectations were high for a business that is often treated as a premium play in fragrances, nutrition and health ingredients. The headline from this half year is about profitability. Earnings per share for H1 2026 came in at €0.86 and net income from ongoing operations reached €216m, set against a rich trailing P/E of 71.2x that already prices...

Universal Music Group walked into this earnings day with a bruised stock, down over 20% across the past month, yet still carrying a rich trailing P/E of 81x. The immediate question for investors is whether the latest numbers justify that kind of price tag or the recent sell off. The headline is simple. Revenue for the first half reached €6,626m, while adjusted diluted earnings per share for H1 rose to €0.47. At the same time, reported net margin over the trailing 12 months sat at just 2.5%...

In the past quarter, Signify N.V. reported second-quarter 2026 results showing sales of €1,332 million and net income of €18 million, both lower than a year earlier, while also confirming weaker performance for the first half of the year. Alongside these softer earnings, Signify completed a share repurchase program totaling 7,958,627 shares, or 6.41% of its share count, for €166 million, highlighting ongoing capital returns even as profitability tightened. With earnings and net income under...

Magnum Ice Cream earnings put H1 performance in focus Magnum Ice Cream (ENXTAM:MICC) is back in the spotlight after reporting half year 2026 results, with higher sales, lower net income and reaffirmed guidance drawing close attention from investors. See our latest analysis for Magnum Ice Cream. The latest H1 2026 earnings update, along with acquisitions in India and Portugal and the ongoing Turkish antitrust review, comes against a backdrop of firming momentum, with a 90 day share price...

With central banks cautious, inflation signals mixed, and energy prices in focus, many investors are looking for income that feels more reliable than short term market swings. That is where the Dividend Powerhouses screener comes in. It focuses on companies offering more than a 5% dividend yield that is well covered, growing and stable. This approach combines the appeal of income with an emphasis on resilience. In this article you will see three of the candidates from the Dividend Powerhouses...

BE Semiconductor Industries (ENXTAM:BESI) has drawn fresh attention after reporting half year 2026 earnings, with sales of €434.75 million and net income of €140.58 million compared with the prior year period. See our latest analysis for BE Semiconductor Industries. Despite stronger half year figures, BE Semiconductor Industries’ recent share price performance has cooled. The 30 day share price return is down 29.6% and the 90 day return is down 19.8%, while the year to date share price return...

Koninklijke BAM Groep stock has climbed 5.4% over the past week, yet still sits slightly down over the past month, as investors digest a construction group that now earns more on each euro of sales. The fresh half year numbers highlight a net profit margin of 3.3% and a trailing P/E of 12.6 that sits below both the industry and peer averages. The real story is the valuation gap. A discounted cash flow estimate of €19.74 against a €11.59 share price raises a longer term question about how much...

ArcelorMittal stock closed at €60.74, capping a strong recent run with double digit gains over the past month. Yet the real story sits inside the earnings print. Q2 2026 delivered solid scale with revenue of $16,761m and net income of $683m, but the sharper focus is on profitability. Trailing net margin stands at 2.9% compared with 4.1% a year earlier, and reported earnings still include a sizeable one off gain of $513m. The short term price strength meets a more nuanced earnings picture that...

Allfunds Group stock closed at €8.84 today after a steady run in recent weeks. The immediate takeaway for investors is not the share price level; it is the strength of the earnings engine that just printed a 10% year on year rise in net revenues to €337.6m and kept adjusted EBITDA margins close to 68%. The market sees a platform stock with a trailing P/E of 129.7x and a history that only recently swung back to profit. The focus now is on whether this phase of profitability can support that...

Koninklijke Vopak stock has quietly climbed about 15% over the past three months and sat near €48.98 into this earnings print. The market had already priced in a solid run, yet the headline today is about cash rather than hype. Proportional EBITDA guidance is now set between €1.18b and €1.22b for 2026, and management is pointing to around €820m in proportional operating free cash flow. For an energy storage and terminals business, where cash generation and leverage matter more than headline...

CTP is trading at €15.58 after a choppy few months, with the stock drifting roughly 4% lower over both the past week and past quarter. The market has been leaning cautious. Yet the headline from this quarter is not the share price. It is a sharp swing from healthy profit in recent periods to a Q2 net loss of €112.5m and basic earnings per share of €0.24 loss. For a logistics real estate operator that is often judged on recurring earnings, that profit squeeze is the number investors are...

Pharming Group went into this earnings day with the stock under pressure, down roughly 39% over the past three months and closing at €0.8782. Yet the headline from the numbers is not collapse; it is a profitability reset that clashes with the gloomy share price trend. Q2 total revenue came in at US$90.2m with net income of US$1.6m, and earnings per share moved back into positive territory. The market is still trading Pharming Group like a problem story, while the income statement reads more...